Research Brief: Specific Care Plan Does Little for AD Patients
evidence-based guidelines,” he wrote.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2482
379 RESULTS
You searched Esther
Sort By:
evidence-based guidelines,” he wrote.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2482
testing the therapeutic potential of anti-PrP antibodies, Rowan noted.—Esther Landhuis None
studies.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3524 Alzheimer's Disease Imaging
adapt to input changes.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2474
identify high-risk individuals before they deteriorate.—Esther Landhuis None
a Phase 3 AD trial (see ARF related news story).—Esther Landhuis None
the gene contributes to AD pathogenesis, Cruchaga told Alzforum.—Esther Landhuis None Alzheimer's
said.—Esther Landhuis Esther Landhuis is a science writer in Dublin, California. None
wreaks havoc in the brain in AD and related diseases. For more on that, see Part 3 of this series.—Esther
control antibodies to tubulin, were able to block QDAβ aggregation.—Esther Landhuis None
variants in the larger genomewide screens, the authors say.—Esther Landhuis None
hypoxia in CAA and AD might be worthy of further scrutiny.—Esther Landhuis, Tom Fagan None
next month at the ICAD meeting.—Esther Landhuis. None http://www.alzforum.org/new/detail.asp?id=1852
dysregulated gene-jumping frequencies compared to healthy people.—Esther Landhuis None
inferences about change (in dementia estimates).”—Esther Landhuis None